Clinical trials are essential in developing new, improved, and more effective treatments and interventions. Without trials, researchers and professionals in the field cannot properly determine whether these new treatments and interventions are safe and effective.
Furthermore, when larger group testing occurs, this allows researchers to identify and ensure that any improvements resulting from the intervention occurs for as many people as possible and are not just occurring in one individual.
Ahead of the J.P. Morgan Health Conference in San Francisco in January 2023, Australian Health Journal met with Clinials CEO & Founder Maree Beare about developing the next generation recruitment platform and digital marketing service for clinical research. Maree talks about the reasons why clinical trials can fail and the importance of bringing participants much more closer to researchers.
With this need, the Clinials platform is geared towards patient centric trials and reducing site burden. The aim is to accelerate lifesaving medicines coming to market by connecting participants and researchers. The platform allows participants to come to researchers with their eligibility in hand among other capabilities.
Supporting CRO’s, sites and sponsors, the Clinials platform uses AI to convert complex trial protocol into plain language and pre-screening questions. This gives researchers the tools to communicate with their participants meaningfully. The plain language text can be used in a variety of situations like researcher led advertising, landing pages and plain language summaries.
-
Sydney North Neighbourhood Health Hubs to approach health and welfare in holistic way
Many people struggle to access the right care at the right time, leading to gaps, delays, and confusion when navigating the health system. By fostering collaboration and integration, the Wellbeing Collaborative will support a primary care system that works better together, making it easier for individuals to receive early intervention and preventative care. By working together and in partnership, Sydney North Health Network aim to create more connected, accessible, and person-centred services that address key health challenges locally, including chronic illness, mental health, aged care, alcohol and other drugs (AOD), and suicide prevention.
-
Awareness campaigns and HCP Toolkits for thyroid health
In 2021, the Australian Thyroid Foundation released analysis to show, well over 1 million Australian are living with an undiagnosed thyroid disorder, including thyroid cancer, lower IQs, lifelong disability, and a causal or possible contributory factor – in the development of other neurological disorders such as ADHD and autism. Some of the challenges for diagnosis and treatment can be addressed by producing material for health care practitioners during patient presentations.
‘Recent statistics show well over 1 million Australians are living with an undiagnosed thyroid disorder, awareness and testing can prevent unwarranted outcomes for mothers and their babies’ says ATF CEO Beverley Garside OAM
The Australian Thyroid Foundation has lodged a Pre-Budget Submission for the Federal Budget 2024-25 to counter increasing misinformation on social media creating dietary deficiencies such as an increasing number of young women, who are planning pregnancy or already pregnant opting for plant based milks such almond, soy or oat milk coffee as an alternative to standard cow’s milk, which is a source of iodine and alternate milks do not include.
-
Jack Lancaster, Evolution Surgical
Continuing the Australian Health Journal, People In Health Care series is Jack Lancaster, the CEO of Evolution Surgical, an Australian owned company established in 2014, specialising in spinal fusion implants and custom instrumentation.
Jack talks about how the company works closely with surgeons to design custom solutions manufactured to surgical requirements, and ultimately, to the benefit of the Australia patient.
